Advanced search
Publication Cover
Drug and Chemical Toxicology Volume 46, 2023 - Issue 5
Submit an article Journal homepage
145
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Acute, repeated inhalation toxicity, respiratory system irritation, and mutagenicity studies of 1,1,2,2-tetrafluoroethane (HFC-134) as the impurity in the pharmaceutical propellant 1,1,1,2-tetrafluoroethane (HFA-134a)

Yanjun Zhaoa NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China;b National Institutes for Food and Drug Control, Beijing, ChinaView further author information
,
Huimin Suna NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China;b National Institutes for Food and Drug Control, Beijing, ChinaView further author information
,
Fei Lina NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China;b National Institutes for Food and Drug Control, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Huiying Yanga NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Beijing, China;b National Institutes for Food and Drug Control, Beijing, ChinaCorrespondence[email protected]
View further author information
Pages 841-850 | Received 17 Mar 2022, Accepted 17 Jul 2022, Published online: 03 Aug 2022

References

  • Alexander, D.J., et al., 1995. An overview of the toxicology of HFA-134a (1,1,1,2-tetrafluoroethane). Human & Experimental Toxicology, 14 (9), 715–720.
  • Araki, A., et al., 1994. Improved method for mutagenicity testing of gaseous compounds by using a gas sampling bag. Mutation Research, 307 (1), 335–344.
  • Brock, T.P., et al., 2006. Readability of brochure about phase-out of chlorofluorocarbons in metered-dose inhalers. American Journal of Health-System Pharmacy, 63 (9), 807–808.
  • Brock, W.J., 1996. Acute, subchronic, and developmental toxicity and genotoxicity of 1,1,1-trifluoroethane (HFC-143a). Fundamental and Applied Toxicology, 31 (2), 200–209.
  • Chinese Pharmacopeia, 2020. Pharmacopoeia of the People's Republic of China (ChP). Beijing: China Medical Science and Technology Press.
  • [ECETOC] European Center for Ecotoxicology and Toxicology of Chemicals, 1990. Joint Assessment of Commodity Chemicals No. 14 1-chloro-2,2,2,-trifluoroethane (HFA-133a). CAS:75-88-7. Brussels: ECETOC.
  • [ECETOC] European Center for Ecotoxicology and Toxicology of Chemicals, 2006. Joint Assessment of Commodity Chemicals No. 50 1,1,1,2-tetrafluoroethane (HFC-134a). CAS:75-88-7. 2nd ed. Brussels: ECETOC.
  • [EP] European Pharmacopeia, 2016. European Pharmacopeia. 9th ed. Strasbourg: Council of Europe.
  • Gehring, D.G., et al., 1992. Chlorofluorocarbons alternatives analysis, part I: the determination of HFC-134a purity by gas chromatography. Journal of Chromatographic Science, 30 (7), 280–284.
  • Kawano, T., 1995. Toxicological evaluation of 1,1,1,2,2-pentafluoroethane (HFC-125). Fundamental and Applied Toxicology, 28 (2), 223–231.
  • Maron, D.M. and Ames, B.N., 1983. Revised methods for the Salmonella mutagenicity test. Mutation Research/Environmental Mutagenesis and Related Subjects, 113 (3–4), 173–215.
  • [NMPA] National Medical Products Administration, 2014a. Guidance for single dose acute toxicity testing for pharmaceuticals. Beijing: NMPA.
  • [NMPA] National Medical Products Administration, 2014b. Guidance for irritation, sensitization and hemolysis testing of drug products. Beijing: NMPA.
  • [NMPA] National Medical Products Administration, 2014c. Guideline for repeated dose toxicity of drug products. Beijing: NMPA.
  • [NRC] National Research Council, 2002. Acute exposure guideline levels for selected airborne chemicals. Vol. 2. Washington (DC): National Academies Press.
  • [OECD] Organization for Economic Cooperation and Development, 2009. Test no. 403: acute inhalation toxicity, OECD guidelines for the testing of chemicals, section 4. Paris: OECD.
  • [OECD] Organization for Economic Cooperation and Development, 2018. Test no. 412: subacute inhalation toxicity: 28-day study, section 4. Paris: OECD.
  • [OECD] Organization for Economic Cooperation and Development, 2020. Test no. 471: bacterial reverse mutation test, section 4. Paris: OECD.
  • Ritchie, G.D., et al., 2001. Acute neurobehavioral effects in rats from exposure to HFC 134a or CFC 12. Neurotoxicology, 22 (2), 233–248.
  • Rusch, G.M., et al., 1999. The acute, genetic, developmental, and inhalation toxicology of 1,1,1,3,3-pentafluoropropane (HFC 245fa). Toxicological Sciences, 52 (2), 289–301.
  • Rusch, G.M., et al., 2013. The acute, genetic, developmental and inhalation toxicology of trans-1,3,3,3-tetrafluoropropene (HFO-1234ze). Drug and Chemical Toxicology, 36 (2), 170–180.
  • Stein, S.W. and Thiel, C.G., 2017. The history of therapeutic aerosols: a chronological review. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 30 (1), 20–41.
  • The Kigali Amendment, 2016. The Montreal Protocol on substances that deplete the ozone layer. Kigali: The Kigali Amendment: The amendment to the Montreal Protocol agreed by the Twenty-Eighth Meeting of the Parties.
  • [USP] The United States Pharmacopeia, 2018. USP41-NF36 S1. New York: United States Pharmacopeial Convention, Inc.
  • Thoolen, B., et al., 2010. Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system. Toxicologic Pathology, 38 (7 Suppl.), 5S–81S.
  • Tveit, A., et al., 2013. The acute, developmental, genetic and inhalation toxicology of 2,3,3,3-tetrafluoropropene (HFO-1234yf). Drug and Chemical Toxicology, 36 (4), 412–420.
  • [CDER] U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, 2018. Metered dose inhaler (MDI) and dry powder inhaler (DPI) products-quality considerations guidance for industry (DRAFT GUIDANCE). Rockville: CDER.
  • Workplace Environmental Exposure Level, 2019. 1,1,2,2-Tetrafluoroethane (HFC-134) (2018). Toxicology and Industrial Health, 35 (3), 196–203.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.